Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide effects on cardiac structure, function, and coronary lesions in obesity
ChiCTR2600134544Phase 4Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Apr 2026
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tirzepatide in obesity, sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Change in Epicardial Adipose Tissue Volume at week 52. Started Apr 2026; status: recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on ChiCTR2600134544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600134544.